🔎 Trials Near Me

Akèy › Adenokasinom Ezofajyen › Illinois › Evanston

Etid klinik pou Adenokasinom Ezofajyen nan Evanston, IL

6 etid pou Adenokasinom Ezofajyen ap chèche patisipan nan sit nan ak bò kote Evanston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Ap rekriteFaz 2/3
  • NorthShore University HealthSystem-Evanston Hospital, Evanston
  • NorthShore University HealthSystem-Glenbrook Hospital, Glenview · 5 mi lwen
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi lwen
  • ak 2 plis
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06203600

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Ap rekriteFaz 3
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05677490

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Ap rekriteFaz 1/2
  • Orchard Healthcare Research Inc.- Skokie, Skokie · 2 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06324357

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

Ap rekriteFaz 2/3
  • Illinois Cancer Specialists, Niles · 6 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07392892

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Ap rekriteFaz 1/2
  • Orchard Healthcare Research Inc, Skokie · 2 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT06330064

Etid Adenokasinom Ezofajyen nan lòt vil

Lòt etid nan Evanston

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.